Delayed Reconstruction for the Non-Amputative Treatment of Subungual Melanoma by 오병호 et al.
Non-Amputative Treatment of Subungual Melanoma
Vol. 27, No. 4, 2015 417
Received August 25, 2014, Revised November 25, 2014, Accepted for 
publication December 15, 2014
Corresponding author: Kee Yang Chung, Department of Dermatology, 
Severance Hospital, Cutaneous Biology Research Institute, Yonsei 
University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 
120-752, Korea. Tel: 82-2-2228-2080, Fax: 82-2-393-9157, E-mail: 
kychung@yuhs.ac
This is an Open Access article distributed under the terms of the 
Creative Commons Attribution Non-Commercial License (http:// 
creativecommons.org/licenses/by-nc/4.0) which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
Ann Dermatol Vol. 27, No. 4, 2015 http://dx.doi.org/10.5021/ad.2015.27.4.417
ORIGINAL ARTICLE
Delayed Reconstruction for the Non-Amputative 
Treatment of Subungual Melanoma
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Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, 
1Department of Dermatology, Yonsei University Health System, Seoul, Korea
Background: In cases of early stage subungual melanoma 
(SUM), conservative treatment with non-amputative wide 
excision of the nail unit and subsequent skin graft is preferred 
over amputation to preserve the involved digit. Objective: 
We report a series of patients with SUM treated with con-
servative surgery and suggest an effective supplementary 
treatment process. Methods: We retrospectively reviewed 
10 patients (2 males, 8 females) who were diagnosed with in 
situ or minimally invasive SUM on the first biopsy and under-
went non-amputative wide excision of the nail unit. All pa-
tients underwent secondary intention healing during the his-
topathological re-evaluation of the entire excised lesion, and 
additional treatment was administered according to the final 
report. Results: In two of 10 patients, amputation was per-
formed because of the detection of deep invasion (Breslow 
thickness: 4.0, 2.3 mm) from the final pathologic results, 
which differed from the initial biopsy. In six patients who re-
ceived delayed skin graft, the mean total time required for 
complete healing after secondary intention healing and the 
skin graft was 66.83±15.09 days. As a result of this delayed 
skin graft, the final scarring was similar to the original shape 
of the nail unit, scored between 5 and 10 on a visual analogue 
scale. Most patients were satisfied with this conservative sur-
gery except one patient, who had volar portion involvement 
and received an interpolated flap instead of a skin graft. 
Conclusion: Our treatment process can reduce the risk of in-
complete resection and improve cosmetic outcomes in pa-
tients with SUM. (Ann Dermatol 27(4) 417∼422, 2015)
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INTRODUCTION
Subungual melanoma (SUM) accounts for approximately 
20% of all melanomas in dark-skinned and Asian pop-
ulations1. Since early skin biopsy of the nail is difficult, di-
agnosis of SUM is often delayed and they are usually diag-
nosed at advanced stages, resulting in poor prognosis2,3. 
On the basis of the rarity of SUM in Caucasian people and 
its poor prognosis, amputation was conventionally the 
treatment of choice for SUM into the 1980s and even 
1990s; the main concern was determining how much of 
the finger to amputate depending on the tumor depth and 
ulceration4-6.
As the treatment of SUM by finger or toe amputation re-
sults in severe functional, esthetic, and psychological im-
pairment7, conservative surgery without amputation has 
been attempted for SUM in situ or SUM with a low level 
of dermal invasion, showing favorable cosmetic and func-
tional outcomes8-10. In addition, conservative surgery does 
not worsen the prognosis of patients with minimally in-
vasive SUM, although data are limited because of the rar-
ity of SUM8,11,12.
To perform this non-amputative procedure, it is a pre-
requisite that conservative surgery is sufficient for tumor 
clearance in the case of SUM. The nail unit has unique 
anatomical characteristics, and the invasion depth of the 
BH Oh, et al
418 Ann Dermatol
Fig. 1. Diagram of treatment process.
SUM varies according to the anatomical part13,14. Therefore, 
the decision to perform conservative surgery on the ba-
sis of the first biopsy result carries a risk of incomplete 
resection.
We delayed reconstruction until we received the final his-
topathological report of the entire excised lesion, and then 
further amputation or reconstruction was decided on ac-
cording to the report. Here, we report a series of SUM pa-
tients treated with this modality and propose an effective 
treatment protocol for SUM based on the clinical out-
comes of these cases.
MATERIALS AND METHODS
Patients and methods
We retrospectively reviewed 10 patients (two males, eight 
females) who underwent non-amputative wide excision of 
the nail unit as the first-choice treatment for SUM from 
October 2006 to August 2011 at the Severance Hospital, 
Yonsei University Health System, Seoul, Korea. All pa-
tients were histopathologically diagnosed with SUM in 
situ or with a low level of dermal invasion (i.e., no evi-
dence of bone invasion) upon the initial nail unit biopsy14. 
We reviewed each patient’s medical records, including 
age, sex, onset location, clinical photos, treatment meth-
ods and duration, and the presence of complications. The 
study protocol was approved by the institutional review 
board of Yonsei University Severance Hospital (IRB No. 
4-2013-0707) and was conducted according to the 
Declaration of Helsinki Principles.
Pathological re-evaluation and surgical management
The initial treatment for the patients was wide excision 
(Fig. 1). The safety margin was 0.5 cm from pigmented le-
sions in case of positive Hutchinson’s sign, and 0.5 cm 
from the nail structure in case of negative Hutchinson’s 
sign. For the deep margin, everything above the periosteum 
was removed. Histopathological re-examination was sub-
sequently performed on the tissue removed en bloc. Each 
specimen was initially sliced along its longitudinal axis 
from the proximal nail fold to the hyponychium at 2-mm 
intervals, and histologic examinations of 4 sequential 4-
μm-thick sections were performed. Tissue staining with 
hematoxylin and eosin, S-100 protein, HMB45, and 
Melan A was performed, and the Breslow thickness (from 
the lowest level of the nail plate to the bottom of the tu-
mor) was recalculated.
During the histopathological re-evaluation, closed wound 
dressing was applied to the skin defect and changed every 
3∼4 days. At each visit, the wound was cleansed with 
1% povidone iodine solution, and a non-adherent porous 
silicone wound contact layer (Mepitel; Mölnlycke Health 
Care, Gothenburg, Sweden) was applied directly to the 
wound, followed by a nonadherent absorbent contact lay-
er made from polyurethane foam (Mepilex; Mölnlycke 
Health Care). Once in position, the dressing was held in 
place with a bandage or other suitable retention aid.
Depending on the final pathological report, amputation 
was performed if the melanoma extended into the deep 
margin, while delayed skin graft was performed if there 
was no extension. In patients who underwent skin graft, a 
sufficient secondary healing period was provided to en-
sure the growth of adequately thick granulation tissues to 
cover up the exposed bone and reduce the defect area for 
grafting. Full-thickness skin graft (FTSG), approximating 
the size and shape of the original nail, was conducted us-
ing a small piece of skin harvested from lower abdomen 
(Fig. 2).
Evaluation of the clinical outcomes
To evaluate clinical outcomes, images of SUM patients 
treated with delayed skin graft were taken at the time of 
complete healing, and evaluations were performed by two 
individual dermatologists using a visual analog scale (VAS). 
The VAS is a 10-cm linear scale in which the left and right 
sides reflect the worst (score of 0) and best (score of 10) 
outcomes, respectively. In addition, patient satisfaction 
was evaluated at the end of treatment according to a 
4-point grading scale (0=unsatisfied, 1=slightly satisfied, 
2=satisfied, 3=very satisfied).
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Fig. 2. Images of clinical progress. 
(A) Case no. 9. An 18-year-old fe-
male patient was diagnosed with 
melanoma in situ from the initial 
skin biopsy. (B) Excision with a 0.5- 
cm-wide margin was performed, 
and tumor clearance was subse-
quently confirmed by histopatholo-
gical re-evaluation in the entire ex-
cised lesion. (C) The deep margin 
was bone contact. (D) Granulation 
tissues were sufficiently formed du-
ring a secondary healing period of 
34 days after wide excision. (E) 
Skin graft was subsequently perfor-
med. (F) Complete healing was ob-
served 16 days after skin graft.
RESULTS
The mean age of the 10 SUM patients who received non-am-
putative wide excision of the nail unit as the first-choice 
treatment was 46.4 years (range, 18∼76 years). Two out 
of 10 patients received amputation as an additional treat-
ment, because the final pathologic result revealed deep in-
vasion (case no. 1: Breslow thickness=2.3 mm; case no. 
3: Breslow thickness=4.0 mm) in the completely excised 
lesion (Table 1). Although no deep invasion was observed 
in case no. 2, amputation was performed because the pa-
tient complained of severe pain and the skin graft was ex-
pected to be difficult due to a skin defect involving the 
volar portion after wide excision. In another case of volar 
portion involvement (case no. 4), an interpolated flap was 
performed using the skin of the adjacent fingers to restore 
the skin defect (Fig. 3). The other six patients’ skin defects 
were restored by FTSG after confirming tumor clearance. 
Recurrence was not observed in any patient during fol-
low-up period (range, 10∼69 months).
In the six patients who received FTSG, the time re-
quired for secondary healing before the skin graft was 
35.83±6.71 days (mean±standard deviation) on average, 
and the mean duration required for complete healing after 
skin graft was 31.00±12.28 days (range, 16∼49 days). 
However, in case no. 4 who received interpolated flap, 
the time required for secondary healing was 59 days, and 
the period required for complete healing was 91 days. 
Furthermore, the patient complained of intermittent pain 
during this period (Table 2).
As a result of delayed skin graft after pathologic re-evalua-
tion, final scarring was similar to the original shape of 
the nail unit, and VAS scores ranged from 5∼10 (mean, 
6.25±1.48). Almost all patients were satisfied with this 
surgery protocol, scoring 2 (satisfied) to 3 (very satisfied) 
on the 4-point grading scale, except the patient of case no. 
4, who had volar portion involvement and received an in-
terpolated flap (Table 2).
DISCUSSION
The invasion depth of SUM may vary depending on the 
special parts of the nail, such as the nail matrix, nail bed, 
and hyponychium, owing to the anatomical nature of 
nails3,13. While these special characteristics of SUM should 
be considered in the staging of melanoma and selecting 
an appropriate treatment method, even recent treatment 
guidelines do not present clear instructions for SUM treat-
ment, possibly because SUM is rare among Caucasians15-18. 
In addition, various conservative surgeries that have re-
cently been attempted to treat SUM in situ or in SUM with 
minimal invasion may have a risk of incomplete resection 
if repair is performed immediately after wide excision 
without pathological re-examination of the overall excised 
lesion. 
In two of 10 cases in the present series, in contrast to the 
initial histological findings, deep invasion of SUM was 
identified with Breslow thicknesses of 4.0 mm and 2.3 
mm in two cases by the final histopathological re-evalua-
tion of the entire tumor, and amputations were performed. 
In particular, we administered adjuvant interferon for case 
no. 3, whose final result also showed neurotrophism of 
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Tx: treatment, M: male, F: female, WE: wide excision, FFT: free-from tumor, PIP: proximal interphalangeal joint, NA: not applied, 
IP: interphalangeal joint, FTSG: full thickness skin graft.
neoplastic melanocytes, which has a high risk of local re-
currence19. Therefore, our delayed treatment process has 
the advantage of clearing the tumor through the re-evalua-
tion of the completely excised lesion.
Another important feature of our treatment process is that 
secondary intention healing was applied to restore the 
skin defect of the nail unit during the period required for 
pathological re-examination. Several reports suggest sec-
ondary healing is better than skin grafting for fingertip am-
putation, resulting in good restoration of the original soft 
tissue thickness and sensation in the injured area20-23. In 
the skin defects of our patients, remarkable restoration of 
the nail folds and hyponychium was achieved with secon-
dary intention healing during the re-evaluation period, al-
most to a degree that could be considered regeneration. In 
addition, sufficient granulation tissue was allowed to grow 
over the exposed bone before the skin graft, and its abun-
dant blood supply may have been the reason for the ex-
cellent survival of the grafted skin. As the size and shape 
of the skin graft matched that of the original nail, the con-
tracted grafted skin resembled a nail, making it more cos-
metically acceptable than a smooth fingertip without a 
nail. For these reasons, VAS scores of SUM patients treat-
ed with delayed skin graft were content, and the majority 
of patients were also satisfied with their conservative 
surgery.
The drawbacks of our treatment process include the time 
required for the final determination of complete tumor re-
moval and the prolonged treatment period for sufficient 
granulation tissue formation, because SUM is treated in 
two sessions. In particular, if the scope of wide excision 
involves the volar portion, problems such as severe pain, 
prolonged healing time, etc., may occur during the treat-
ment course. In case no. 4, which was treated with an in-
terpolated flap on the skin defect of the volar portion, the 
patient complained of intermittent pain and took longer to 
heal completely than patients who received skin graft (91 
vs. 31±12.28 days). Therefore, sufficiently explaining the 
treatment process to patients is important, and the pa-
tient’s opinion should play a role in treatment selection.
In conclusion, although there were too few cases to ana-
lyze the effects of non-amputative wide excision of the 
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Fig. 3. Clinical images of case case 
no. 4 (female/76). (A) Wide exci-
sion was performed with a 0.5-cm 
safety margin from the pigmented 
lesion and nail structure. (B) Two 
months later, an interpolated flap 
was made using the skin of the 
adjacent fingers to restore the skin 
defect.































 5 F/41 Great toe − Delayed FTSG 30 26 - 2 7
 6 F/57 Great toe − Delayed FTSG 38 35 - 3 9.5
 7 F/28 4th finger − Delayed FTSG 42 21 - 2 6.5
 8 F/40 1st finger − Delayed FTSG 44 49 - 2 5.5
 9 F/18 1st finger − Delayed FTSG 34 16 - 2 5
10 F/32 2nd finger − Delayed FTSG 27 39 - 2 5
SUM: subungual melanoma, Tx: treatment, VAS: visual analog scale (evaluated by two individual dermatologists), F: female, FTSG: 
full thickness skin graft. Patients’ satisfaction: 0=unsatisfied, 1=slightly satisfied, 2=satisfied, 3=very satisfied. 
nail unit and delayed repair on patient survival rate, the 
present findings support the fundamental oncologic princi-
ple of “tumor clearance first, reconstruction second.” Thus, 
this delayed approach could significantly reduce the risk 
of incomplete resection and improve cosmetic outcomes.
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